Cancer Genetics, Inc. to receive $1.0 milliont through New Jersey tax credit program
Cancer Genetics, Inc. announced it has received approval for a $1.0 million gross tax credit from the New Jersey Technology Business Tax Certificate Transfer Program. The company has received over $950,000 in net cash as a result of the tax credit transfer during the first quarter of 2017. February 22, 2017